CoChat

European Society of Hypertension position paper on renal denervation 2021

Open access
Schmieder, Roland E., Mahfoud, Felix, Mancia, Giuseppe, Azizi, Michael, Böhm, Michael, Dimitriadis, Kyriakos, Kario, Kazuomi, Kroon, Abraham A., D Lobo, Melvin, Ott, Christian, Pathak, Atul, Persu, Alexandre, Scalise, Filippo, Schlaich, Markus, Kreutz, Reinhold, Tsioufis, Costas · 2021 · Journal of Hypertension
Cited by 131

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

This ESH Position Paper 2021 with updated proposed recommendations was deemed necessary after the publication of a set of new pivotal sham-controlled randomized clinical trials (RCTs), which provided important information about the efficacy and safety of endovascular device-based renal denervation (RDN) for hypertension treatment. RDN is effective in reducing or interrupting the sympathetic signals to the kidneys and decreasing whole body sympathetic activity. Five independent, fully completed, sham-controlled RCTs provide conclusive evidence that RDN lowers ambulatory and office blood pressure (BP) to a significantly greater extent than sham treatment. BP-lowering efficacy is evident both in patients with and without concomitant antihypertensive medication. The average decrease of 10 mmHg in office BP is estimated to lower the incidence of cardiovascular events by 25–30%, based on meta-analyses of RCTs using pharmacological treatment. Neither peri-procedural, nor short-term or long-term adverse events or safety signals (available up to 3 years) have been observed. Implementing RDN as an innovative third option in the armamentarium of antihypertensive treatment requires a structured process that ensures the appropriate performance of the endovascular RDN procedure and adequate selection of hypertensive patients. The latter should also incorporate patients’ perspective and preference that needs to be respected in a shared decision-making process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0000000000002933

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 131

Metadata

Authors
Schmieder, R. E., Mahfoud, F., Mancia, G., Azizi, M., Böhm, M., Dimitriadis, K., Kario, K., Kroon, A. A., D Lobo, M., Ott, C., Pathak, A., Persu, A., Scalise, F., Schlaich, M., Kreutz, R., & Tsioufis, C.
Venue
Journal of Hypertension
Published
2021-07-13
Volume
39
Issue
9
Pages
1733-1741
ISSN
  • 0263-6352 (ISSN-L)
  • 1473-5598
OpenAlex
W3178407368
Cited by
131
References
11
FWCI
17.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Society of Hypertension position paper on renal denervation 2021. https://app.cochat.ai/papers/10.1097/hjh.0000000000002933
The paper
Schmieder, R. E., Mahfoud, F., Mancia, G., Azizi, M., Böhm, M., Dimitriadis, K., Kario, K., Kroon, A. A., D Lobo, M., Ott, C., Pathak, A., Persu, A., Scalise, F., Schlaich, M., Kreutz, R., & Tsioufis, C. (2021). European Society of Hypertension position paper on renal denervation 2021. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000002933

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.